Vimarsana
Biggest News Aggregation in the World

Page 9 - Robert Barrow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Barrow Today - Breaking & Trending Today

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $24.83 Consensus Target Price from Analysts - Vimarsana News

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $24.83 Consensus Target Price from Analysts

Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have covered the stock in the […]

Putin's arms shipments no longer dare enter the Black Sea. Russia is losing the logistic war - Vimarsana News

Putin's arms shipments no longer dare enter the Black Sea. Russia is losing the logistic war

The maritime environment is one with logistics, not warfare, at its core. As someone who spent a career training for the latter, it pains me to say it, but this is the reality.

Source: yahoo.com
Putin's arms shipments no longer dare enter the Black Sea. Russia is losing the logistic war - Vimarsana News

Putin's arms shipments no longer dare enter the Black Sea. Russia is losing the logistic war

The maritime environment is one with logistics, not warfare, at its core. As someone who spent a career training for the latter, it pains me to say it, but this is the reality.

Source: yahoo.com
FDA Grants Breakthrough Therapy Status To LSD Drug To Treat Anxiety - Vimarsana News

FDA Grants Breakthrough Therapy Status To LSD Drug To Treat Anxiety

New research shows that a form of LSD may be an effective treatment for generalized anxiety disorder, with the FDA designating the drug as a breakthrough therapy.

Source: forbes.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Price Target Raised to $15.00 at Royal Bank of Canada - Vimarsana News

Mind Medicine (MindMed) (NASDAQ:MNMD) Price Target Raised to $15.00 at Royal Bank of Canada

Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) had its price objective raised by Royal Bank of Canada from $14.00 to $15.00 in a research report released on Thursday, Benzinga reports. The brokerage currently has an outperform rating on the stock. Separately, Canaccord Genuity Group assumed coverage on Mind Medicine (MindMed) in a report on Tuesday, […]

Source: wkrb13.com